D3 and D2 dopamine receptor agonists differentially modulate isolation-induced social-emotional reactivity in mice

Behavioural Brain Research

Volumn 114, Issue 1-2, 2000, Pages 107-117

  Gendreau, Paul L ^a   Petitto, John M ^a   Petrova, Andreana ^a   Gariépy, Jean Louis ^b   Lewis, Mark H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Anxiety; D3 receptors; Defensive behavior; Dopamine; Emotional behavior; Fear; Social behavior

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT;

AGGRESSION; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; EMOTION; FEAR; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL ADAPTATION; SOCIAL ISOLATION;

AGGRESSION; ANIMAL; BENZOPYRANS; DOPAMINE AGONISTS; EMOTIONS; MALE; MICE; MICE, INBRED A; MICE, INBRED C57BL; OXAZINES; RECEPTORS, DOPAMINE D2; SOCIAL BEHAVIOR; SOCIAL ENVIRONMENT; SOCIAL ISOLATION; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDRONAPHTHALENES;

EID: 0034283479     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00193-5     Document Type: Article

References (87)

1. Ahlenius S., Salmi P. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmacol. 260:1994;177-181.
2. Aguilar M.A., Miñarro J., Pérez-Iranzo N., Simón V.M. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 47:1994;753-756.
3. Ahmed S.H., Stinus L., Le Moal M., Cador M. Social deprivation enhances the vulnerability of male Wistar rats to stressor- and amphetamine-induced behavioral sensitization. Psychopharmacology. 117:1995;116-124.
4. 3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells. Life Sci. 57:1995;1401-1410.
5. Bartoszyk G.D. Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. Life Sci. 62:1998;649-663.
6. Blackburn J.R., Pfaus J.G., Phillips A.G. Dopamine functions in appetitive and defensive behaviours. Prog. Neurobiol. 39:1992;247-279.
7. Blanchard R.J., Yudko E.B., Rodgers R.J., Blanchard D.C. Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav. Brain Res. 58:1993;155-165.
8. Boulay D., Depoortere R., Rostene W., Perreault G., Sanger D.J. Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor reactivity in D3 knock-out and wild-type mice. Neuropharmacology. 38:1999;555-565.
9. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564:1991;203-219.
10. Cabib S., Puglisi-Allegra S. Genotype-dependent modulation of LY 171555-induced defensive behavior in the mouse. Psychopharmacology. 97:1989;166-168.
11. Cairns R.B., MacCombie D.J., Hood K.E. A developmental-genetic analysis of fighting in mice: I. Behavioral outcome. J. Comp. Physiol. Psychol. 97:1983;69-89.
12. Crawley J.N. Evaluation of a proposed hamster separation model of depression. Psych. Res. 11:1984;35-47.
13. Daly S.A., Waddington J.L. Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other 'D-2-like' agonists'. Neuropharmacology. 32:1993;509-510.
14. Davis R.E. Readiness to display in the Paradise fish Macropodus opercularis, L., Belontiidae: the problem of general and specific effects of social isolation. Behav. Biol. 15:1975;419-433.
15. Dixon A.K., Huber C., Lowe D.A. Clozapine promotes approach-oriented behavior in male mice. J. Clin. Psychiatry. 55(Suppl B):1994;4-7.
16. Ferrari F., Guiliani D. Behavioural assessment in rats of the antipsychotic potential of the potent dopamine D2 receptor antagonist, (-) eticlopride. Pharmacol. Res. 31:1995;261-267.
17. Fink J.S., Reis D.J. Genetic variations in midbrain dopamine cell number: parallel with differences in responses to dopaminergic agonists and in naturalistic behaviors mediated by central dopaminergic systems. Brain Res. 222:1981;335-349.
18. Franklin S.R., Tang A.H. Dopamine agonists facilitate footshock-elicited locomotion in rats, and suppress lever-press responding for food. Psychopharmacology. 121:1995;480-484.
19. Gao B., Cutler M.G. Effects of quinpirole of the behaviour shown by mice in the light-dark box and during social interactions. Neuropharmacology. 32:1993;93-100.
20. Gariépy J.-L. The mediation of aggression in mice: a discussion of approach-withdrawal processes in social adaptation. Hood K.E., Tobach E., Greenberg G. Behavioral Development: Concepts Of Approach-Withdrawal and Integrative Levels. 1995;231-284 Garland Press, New York.
21. Gariépy J.-L., Gendreau P.L., Cairns R.B., Lewis M.H. D1 dopamine receptors and the reversal of isolation-induced behaviors in mice. Behav. Brain Res. 95:1998;103-111.
22. Gariépy J.-L., Gendreau P.L., Mailman R.B., Tancer M.E., Lewis M.H. Rearing conditions alter social reactivity and D1 dopamine receptors in high- and low-aggressive mice. Pharmacol. Biochem. Behav. 51:1995;767-773.
23. Gariépy J.-L., Hood K.E., Cairns R.B. A developmental-genetic analysis of aggressive behavior in mice: III. Behavioral mediation by heightened reactivity or increased immobility? J. Comp. Physiol. Psychol. 102:1988;392-399.
24. Gendreau P.L., Petitto J.M., Gariépy J.-L., Lewis M.H. D1 dopamine receptor mediation of social and nonsocial emotional reactivity in mice: effects of housing and strain difference in motor activity. Behav. Neurosci. 111:1997;454-464.
25. Gendreau P.L., Petitto J.M., Gariépy J.-L., Lewis M.H. D2-like dopamine receptor mediation of social-emotional reactivity in a mouse model of anxiety: strain and experience effects. Neuropsychopharmacology. 18:1998;210-221.
26. Gendreau P.L., Petitto J.M., Schnauss R., Frantz K.J., Van Hartesveldt C., Gariépy J.-L., Lewis M.H. Effects of the putative dopamine D3 receptor antagonist PNU 99194A on motor behavior and emotional reactivity in C57BL/6J mice. Eur. J. Pharmacol. 337:1997;147-155.
27. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends. Neurosci. 19:1996;177-191.
28. 3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors. Eur. J. Pharmacol. 272:1995;R1-R3.
29. Goosen C. Abnormal behavior patterns in rhesus monkeys: symptoms of mental disease. Biol. Psychiatry. 16:1981;697-716.
30. Grant E.C., Mackintosh J.H. A comparison of the social postures of some common laboratory rodents. Behaviour. 21:1963;246-259.
31. Griffon N., Sautel F., Pilon C., Lévesque D., Sokoloff P., Schwartz J.-C., Diaz J., Simon P., Costentin J., Mann A., Wermuth C.G. Functional models for the dopamine D3 receptor. Biochem. Soc. Transit. 24:1996;193-198.
32. Guisado E., Fernandez-Tome P., Garzón J., Del Rio J. Increased dopamine receptor binding in the striatum of rats after long-term isolation. Eur. J. Pharmacol. 65:1980;463-464.
33. Harlow H.F., Suomi S.J. Induced depression in monkeys. Behav. Biol. 12:1974;273-296.
34. Hatch A.M., Wiberg G.S., Zawiska Z., Cann M., Airth J., Grice H.C. Isolation syndrome in the rat. Toxicol. Appl. Pharmacol. 7:1965;737-745.
35. Jones R.B., Waddington D. Modification of fear in domestic chicks, Gallus gallus domesticus, via regular handling and early environmental enrichment. Anim. Behav. 43:1992;1021-1033.
36. Kagaya T., Yonaga M., Furuya Y., Hashimoto T., Kuroki J., Nishizawa Y. Dopamine D3 agonists disrupt social behavior in rats. Brain Res. 721:1996;229-232.
37. Khroyan T.V., Baker D.A., Neisewander J.L. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology. 122:1995;351-357.
38. Kršiak M. Timid singly-housed mice: their value in prediction of psychotropic activity of drugs. Br. J. Pharmacol. 55:1975;141-150.
39. Lagerspetz K.Y.H., Tirri R., Lagerspetz M.J. Neurochemical and endocrinological studies of mice selectively bred for aggressiveness. Scand. J. Psychol. 9:1968;157-160.
40. Large C.H., Stubbs C.M. The dopamine D3 receptor: Chinese hamsters or Chinese whispers. Trends. Pharmacol. Sci. 15:1994;46-47.
41. Lévesque D. Aminotetralin drugs and D3 receptor functions: what may partially selective D3 receptor ligands tell us about dopamine D3 receptor functions. Biochem. Pharmacol. 52:1996;511-518.
42. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA. 89:1992;8155-8159.
43. Lewis M.H., Gariépy J.L., Gendreau P.L., Nichols D.E., Mailman R.B. Social reactivity and D1 dopamine receptors: studies in mice selectively bred for high and low levels of aggression. Neuropsychopharmacology. 10:1994;115-122.
44. Liu J.C., Cox R.F., Greif G.J., Freedman F.E., Waszczac B.L. The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity. Eur. J. Pharmacol. 264:1994;269-278.
45. 3H]quinpirole binding to human dopamine D2a and D3 receptors: effects on ions and guanine nucleotides. J. Pharmacol. Exp. Ther. 274:1995;790-797.
46. Mason W.A., Green P.C. The effects of social restriction on the behavior of rhesus monkeys: IV. Response to a novel environment and to an alien species. J. Comp. Physiol. Psychol. 55:1962;363-368.
47. Mason W.A., Sponholz R.R. Behavior of rhesus monkeys raised in isolation. J. Psych. Res. 1:1963;299-306.
48. Mathis C., Paul S.M., Crawley J.N. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice. Behav. Genet. 24:1994;171-180.
49. Melzack R. The role of early experience in emotional arousal. J. Comp. Physiol. Psychol. 52:1969;694-698.
50. Menzel E.W., Davenport R.K., Rogers C.M. The effects of environmental restriction upon the chimpanzees responsiveness to objects. J. Comp. Physiol. Psychol. 56:1963;78-85.
51. Miczek K.A., O'Donnell J.M. Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and L-Dopa. Psychopharmacology. 57:1978;47-55.
52. Miczek K.A., Yoshimura H. Disruption of primate social behavior by d-amphetamine and cocaine: differential antagonism by antipsychotics. Psychopharmacology. 76:1982;163-171.
53. Mollenauer S., Jackson C., Pollack T. Amphetamine: differential effects on defensive flight and motor behavior in the rat. Pharmacol. Biochem. Behav. 19:1983;33-37.
54. Murray A.M., Ryoo H.L., Gurevich E., Joyce J.N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. USA. 91:1994;11271-11275.
55. Parsons B., Stanley M., Javitch J. Differential visualization of dopamine D2 and D3 receptors in rat brain. Eur. J. Pharmacol. 234:1993;269-272.
56. Petitto J.M., Lysle D.T., Gariépy J.-L., Lewis M.H. The expression of genetic differences in social behavior in ICR mice correlates with differences in cellular immune responsiveness. Clin. Neuropharmacol. 15:1992;658-659.
57. Piercey M.F., Moon M.W., Sethy V.H., Schreur P.J., Smith M.W., Tang A.H., VonVoigtlander P.F. Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtype. Eur. J. Pharmacol. 317:1996;29-38.
58. Puglisi-Allegra S., Cabib S. Pharmacological evidence for a role of D2 dopamine receptors in the defensive behavior of the mouse. Behav. Neural. Biol. 50:1988;98-111.
59. Pugsley T.A., Davis M.D., Akunne H.C., Mackenzie R.G., Shih Y.H., Damsma G., Wikstrom H., Whetzel S.Z., Georgic L.M., Cooke L.W., Demattos S.B., Corbin A.E., Glase S.A., Wise L.D., Dijkstra D., Heffner T.G. Neurochemical and functional characterization of the preferentially selective D3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275:1995;1355-1366.
60. Redolat R., Brain P.F., Simon V.M. Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacology. 30:1991;41-46.
61. Rodgers R.J., Cole J.C. Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol. Behav. 54:1993;729-736.
62. Rodgers R.J., Johnson N.J.T., Champion A.J., Mills S. Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT. Pharmacol. Biochem. Behav. 54:1996;79-84.
63. Rodgers R.J., Nikulina E.M., Cole J.C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;985-995.
64. Sahakian B.J., Robbins T.W., Morgan M.J., Iversen S.D. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats. Brain Res. 84:1975;195-205.
65. 3H]7-OH-DPAT labels both dopamine D3 receptors and σ sites in the bovine caudate nucleus. Eur. J. Pharmacol. 242:1993;R1-R2.
66. Schwartz J.C., Lévesque D., Martres M.P., Sokoloff P. Dopamine D3 receptor: basic and clinical aspects. Clin. Neuropharmacol. 16:1993;295-314.
67. Seale T.W., McLanahan K., Johnson P., Carney J.M., Rennert O.M. Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors. Pharmacol. Biochem. Behav. 21:1984;234-237.
68. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends. Pharmacol. Sci. 15:1994;264-270.
69. Shafer R.A., Levant B. The D3 dopamine receptor in cellular and organismal function. Psychopharmacology. 135:1998;1-16.
70. Skrinskaya J.A., Nikulina E.M., Popova N.K. Role of the genotype in brain dopamine metabolism and dopamine-dependent behavior of mice. Pharmacol. Biochem. Behav. 42:1992;261-267.
71. Smith R.H. Wildness and domestication in Mus musculus: a behavioral analysis. J. Comp. Physiol. Psychol. 79:1972;22-29.
72. Southwick C.H., Clark L.H. Interstrain differences in aggressive behavior and exploratory activity in inbred mice. Commun. Behav. Biol. 1:1968;49-59.
73. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
74. Starr M.S., Starr B.S. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors. Eur. J. Pharmacol. 277:1995;151-158.
75. Steiner H., Fuchs S., Accili D. D3 dopamine receptor-deficient mouse: Evidence for reduced anxiety. Physiol. Behav. 63:1998;137-141.
76. Suomi S.J. Genetic and maternal contributions to individual differences in rhesus monkey biobehavioral development. Krasnegor N.A., Blass E.M., Hofer M.A., Smotherman W.P. Perinatal development, a psychobiological perspective. 1987;397-419 Academic Press, Orlando.
77. Svensson A., Carlsson A., Waters N. Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural. Transm. 95:1994;71-74.
78. Terranova M.L., Laviola G., Alleva E. Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes. Develop. Psychobiol. 26:1993;467-481.
79. Tidey J.W., Miczek K.A. Effects of SKF 38393 and quinpirole on aggressive, motor and schedule-controlled behaviors in mice. Behav. Pharmacol. 3:1992;553-565.
80. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology. 111:1993;323-331.
81. Turner C.H., Davenport R.K., Rogers C.M. The effects of early deprivation on the social behavior of adolescent chimpanzee. Am. J. Psych. 125:1969;1531-1536.
82. Valzelli L. The 'isolation syndrome' in mice. Psychopharmacologia. 31:1973;305-320.
83. Van den Buuse M. Effects of 7-hydroxy-N, N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats. Eur. J. Pharmacol. 243:1993;169-177.
84. Wilmot C.A., VanderWende C., Spoerlein M.T. Behavioral responses to apomorphine and amphetamine in differentially housed mice. Psychopharmacology. 84:1984;105-108.
85. Wilmot C.A., VanderWende C., Spoerlein M.T. Behavioral and biochemical studies of dopamine receptor sensitivity in differentially housed mice. Psychopharmacology. 89:1986;364-369.
86. Xu M., Koeltzow T.E., Cooper D.C., Tonegawa S., White F.J. Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse. 31:1999;210-215.
87. Yen C.Y., Stanger R.L., Millman N. Ataractic suppression of isolation-induced aggressive behavior. Arch. Int. Pharmacodynamique. Thérapie. 123:1959;179-185.